Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices.

AKT phosphorylation BIRA assay IGF Western immunoblotting bioactivity bioassay capillary immuno-electrophoresis cerebrospinal fluid colostrum mTOR milk serum

Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
24 02 2021
Historique:
received: 24 01 2021
revised: 15 02 2021
accepted: 21 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 16 11 2021
Statut: epublish

Résumé

The bioactivity of the IGF system is not a function of isolated hormone concentrations in a given biological matrix. Instead, the biological activities of IGFs are regulated by IGFBPs, IGFBP proteases, and inhibitors of IGFBP proteases. Therefore, assays based on IGF-related bioactivity may describe functions of the complete IGF system in a given biological matrix. Of particular interest are the IGF system effects on the AKT/mTOR pathway, as a dominant system for controlling growth, metabolism, and aging. In order to improve the sensitivity of IGF-dependent bioactivity, we made use of the known short-term and enhancing effects of IGFBP2 on the intracellular PI3K pathway. As a specific readout of this pathway, and further as a marker of the mTOR pathway, we assessed the phosphorylation of AKT-Ser473. Preincubation using IGFBP2 enhanced IGF1-dependent AKT-Ser473 phosphorylation in our experimental system. The assay's specificity was demonstrated by inhibition of IGF1 receptors outside or inside the cell, using antiserum or small molecule inhibitors, which reduced AKT phosphorylation in response to exogenous IGF1 (

Identifiants

pubmed: 33668197
pii: cells10030482
doi: 10.3390/cells10030482
pmc: PMC7995968
pii:
doi:

Substances chimiques

IGF1 protein, human 0
Insulin-Like Growth Factor I 67763-96-6
MTOR protein, human EC 2.7.1.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : H. Wilhelm Schaumann Stiftung
ID : no grant number

Références

Clin Endocrinol (Oxf). 2014 Jul;81(1):58-62
pubmed: 23865977
Genetics. 1998 Sep;150(1):369-81
pubmed: 9725853
Eur J Obstet Gynecol Reprod Biol. 1989 Jan;30(1):19-25
pubmed: 2924989
Mol Cancer Ther. 2009 Dec;8(12):3341-9
pubmed: 19996272
PLoS One. 2015 Dec 22;10(12):e0145587
pubmed: 26694858
Biol Rev Camb Philos Soc. 2021 Apr;96(2):376-393
pubmed: 33128331
J Pharm Biomed Anal. 1999 May;19(6):883-91
pubmed: 10698554
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3526-3534
pubmed: 28911149
Cells. 2020 Jun 22;9(6):
pubmed: 32580353
EMBO Mol Med. 2017 Oct;9(10):1338-1345
pubmed: 28801361
Cancer Res. 2001 Dec 15;61(24):8601-10
pubmed: 11751371
J Med Chem. 2009 Dec 10;52(23):7360-3
pubmed: 19778024
J Biol Chem. 2015 May 1;290(18):11578-90
pubmed: 25787077
J Alzheimers Dis. 2015;48(3):637-46
pubmed: 26402100
Exp Ther Med. 2016 Jun;11(6):2095-2106
pubmed: 27284291
FEBS Lett. 1982 Nov 22;149(1):105-8
pubmed: 6759171
Pediatr Res. 1999 Jul;46(1):76-81
pubmed: 10400138
Biochem Biophys Res Commun. 1988 Jun 30;153(3):1076-83
pubmed: 3291867
Front Endocrinol (Lausanne). 2020 Aug 27;11:574
pubmed: 32982971
Best Pract Res Clin Endocrinol Metab. 2017 Aug;31(4):409-418
pubmed: 29221569
J Biol Chem. 1983 May 25;258(10):6561-6
pubmed: 6304046
Growth Horm IGF Res. 2008 Jun;18(3):181-7
pubmed: 18308605
Growth Horm IGF Res. 2019 Oct - Dec;48-49:53-59
pubmed: 31670029
FEBS Lett. 1998 Sep 4;434(3):329-34
pubmed: 9742949
Domest Anim Endocrinol. 2012 Aug;43(2):186-97
pubmed: 22153974
Mol Cell Biol. 2012 Oct;32(20):4116-30
pubmed: 22869525
Exp Cell Res. 1982 Dec;142(2):293-300
pubmed: 6756944
J Dairy Res. 2007 Feb;74(1):58-65
pubmed: 16978432
Lab Chip. 2015 Feb 7;15(3):726-34
pubmed: 25428717
Oncotarget. 2015 Oct 13;6(31):32266-78
pubmed: 26336825
Diabetes Obes Metab. 2014 Sep;16 Suppl 1:16-20
pubmed: 25200291
PLoS One. 2012;7(6):e39711
pubmed: 22768110
Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1149-55
pubmed: 12604504
Growth Horm IGF Res. 2017 Aug;35:1-7
pubmed: 28544872
J Biol Chem. 1988 Apr 15;263(11):5436-45
pubmed: 2965702
Front Endocrinol (Lausanne). 2021 Jan 05;11:565557
pubmed: 33469444

Auteurs

Michael Walz (M)

Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Wilhelm-Stahl Allee 2, 18196 Dummerstorf, Germany.

Christine Höflich (C)

Ligandis Biomarker Diagnostics, Dorfstr. 14, 18276 Gülzow-Prüzen, Germany.

Christina Walz (C)

Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Wilhelm-Stahl Allee 2, 18196 Dummerstorf, Germany.

Daniela Ohde (D)

Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Wilhelm-Stahl Allee 2, 18196 Dummerstorf, Germany.

Julia Brenmoehl (J)

Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Wilhelm-Stahl Allee 2, 18196 Dummerstorf, Germany.

Mandy Sawitzky (M)

Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Wilhelm-Stahl Allee 2, 18196 Dummerstorf, Germany.

Andreas Vernunft (A)

Institute of Reproductive Biology, Leibniz Institute for Farm Animal Biology (FBN), Wilhelm-Stahl Allee 2, 18196 Dummerstorf, Germany.

Uwe K Zettl (UK)

Department of Neurology, Neuroimmunological Section, University Medicine Rostock, Gehlsheimer Str. 20, 18147 Rostock, Germany.

Susanne Holtze (S)

Department of Reproduction Management, Leibniz-Institute for Zoo and Wildlife Research, Alfred-Kowalke-Str. 17, 10315 Berlin, Germany.

Thomas B Hildebrandt (TB)

Department of Reproduction Management, Leibniz-Institute for Zoo and Wildlife Research, Alfred-Kowalke-Str. 17, 10315 Berlin, Germany.

Eckhard Wolf (E)

Chair of Molecular Animal Breeding and Biotechnology and Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, Feodor-Lynen-Str. 25, 81377 Munich, Germany.

Andreas Hoeflich (A)

Institute of Genome Biology, Leibniz Institute for Farm Animal Biology (FBN), Wilhelm-Stahl Allee 2, 18196 Dummerstorf, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH